NO986049L - Matrise metallproteinaseinhibitorer - Google Patents
Matrise metallproteinaseinhibitorerInfo
- Publication number
- NO986049L NO986049L NO986049A NO986049A NO986049L NO 986049 L NO986049 L NO 986049L NO 986049 A NO986049 A NO 986049A NO 986049 A NO986049 A NO 986049A NO 986049 L NO986049 L NO 986049L
- Authority
- NO
- Norway
- Prior art keywords
- matrix metal
- proteinase inhibitors
- tnf
- metal proteinase
- mmp
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
- C07D317/66—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9613547.0A GB9613547D0 (en) | 1996-06-27 | 1996-06-27 | Matrix metalloproteinase inhibitors |
| PCT/EP1997/003251 WO1997049674A1 (en) | 1996-06-27 | 1997-06-20 | Matrix metalloproteinase inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO986049D0 NO986049D0 (no) | 1998-12-22 |
| NO986049L true NO986049L (no) | 1999-03-01 |
Family
ID=10796022
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO986049A NO986049L (no) | 1996-06-27 | 1998-12-22 | Matrise metallproteinaseinhibitorer |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0920414A1 (xx) |
| JP (1) | JP2000514043A (xx) |
| KR (1) | KR20000022534A (xx) |
| AR (1) | AR008621A1 (xx) |
| AU (1) | AU733938B2 (xx) |
| BR (1) | BR9709902A (xx) |
| CA (1) | CA2257404A1 (xx) |
| CZ (1) | CZ430398A3 (xx) |
| EA (1) | EA001432B1 (xx) |
| GB (1) | GB9613547D0 (xx) |
| ID (1) | ID17792A (xx) |
| IL (1) | IL127262A0 (xx) |
| NO (1) | NO986049L (xx) |
| NZ (1) | NZ333550A (xx) |
| PL (1) | PL330897A1 (xx) |
| TW (1) | TW460441B (xx) |
| WO (1) | WO1997049674A1 (xx) |
| ZA (1) | ZA975631B (xx) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19719817A1 (de) * | 1997-05-13 | 1998-11-19 | Hoechst Ag | Substituierte 6- und 7-Aminotetrahydroisochinolincarbonsäuren |
| WO1999006340A2 (en) | 1997-07-31 | 1999-02-11 | The Procter & Gamble Company | Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors |
| GB9803005D0 (en) | 1998-02-12 | 1998-04-08 | British Biotech Pharm | Anti-inflammatory agents |
| GB9804777D0 (en) * | 1998-03-07 | 1998-04-29 | British Biotech Pharm | Anti-inflammatory agents |
| US6335324B1 (en) | 1998-06-25 | 2002-01-01 | Bristol-Myers Squibb Co. | Beta lactam compounds and their use as inhibitors of tryptase |
| GB9901863D0 (en) * | 1999-01-29 | 1999-03-17 | British Biotech Pharm | Antibacterial agents |
| EP1165501A1 (en) | 1999-03-03 | 2002-01-02 | The Procter & Gamble Company | Alkenyl- and alkynyl-containing metalloprotease inhibitors |
| AU2268401A (en) * | 1999-12-17 | 2001-06-25 | Versicor Inc | Novel succinate compounds, compositions and methods of use and preparation |
| GB9930754D0 (en) * | 1999-12-29 | 2000-02-16 | Smithkline Beecham Plc | Novel compounds |
| WO2002006227A1 (fr) * | 2000-07-18 | 2002-01-24 | Chugai Seiyaku Kabushiki Kaisha | Inhibiteurs de la metalloprotease matricielle |
| BR0210422A (pt) | 2001-06-15 | 2004-08-17 | Vicuron Pharm Inc | Compostos bicìclicos de pirrolidina |
| AR036053A1 (es) | 2001-06-15 | 2004-08-04 | Versicor Inc | Compuestos de n-formil-hidroxilamina, un proceso para su preparacion y composiciones farmaceuticas |
| US20110230479A1 (en) * | 2005-04-15 | 2011-09-22 | Longo Frank M | Neurotrophin mimetics and uses thereof |
| KR20060116552A (ko) * | 2005-05-10 | 2006-11-15 | 연세대학교 산학협력단 | 매트릭스 메탈로프로테이나제 저해제로서 엔-포르밀히드록실아민 유도체 |
| FR2949463B1 (fr) * | 2009-08-26 | 2011-09-16 | Commissariat Energie Atomique | Inhibiteurs de mmp |
| US10273219B2 (en) | 2009-11-12 | 2019-04-30 | Pharmatrophix, Inc. | Crystalline forms of neurotrophin mimetic compounds and their salts |
| US9271986B2 (en) | 2009-11-12 | 2016-03-01 | Pharmatrophix, Inc. | Crystalline forms of neurotrophin mimetic compounds and their salts |
| JP2022512584A (ja) | 2018-10-04 | 2022-02-07 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | 角皮症を処置するためのｅｇｆｒインヒビター |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4599361A (en) * | 1985-09-10 | 1986-07-08 | G. D. Searle & Co. | Hydroxamic acid based collagenase inhibitors |
| DK77487A (da) * | 1986-03-11 | 1987-09-12 | Hoffmann La Roche | Hydroxylaminderivater |
| HUT62263A (en) * | 1990-12-03 | 1993-04-28 | Celltech Ltd | Process for producing peptidyl derivatives and pharmaceutical compositions comprising such compounds as active ingredient |
| CA2058797A1 (en) * | 1991-02-01 | 1992-08-02 | Michael John Broadhurst | Amino acid derivatives |
| EP0520573A1 (en) * | 1991-06-27 | 1992-12-30 | Glaxo Inc. | Cyclic imide derivatives |
-
1996
- 1996-06-27 GB GBGB9613547.0A patent/GB9613547D0/en active Pending
-
1997
- 1997-06-18 TW TW086108613A patent/TW460441B/zh active
- 1997-06-20 IL IL12726297A patent/IL127262A0/xx unknown
- 1997-06-20 BR BR9709902A patent/BR9709902A/pt unknown
- 1997-06-20 CA CA002257404A patent/CA2257404A1/en not_active Abandoned
- 1997-06-20 NZ NZ333550A patent/NZ333550A/xx unknown
- 1997-06-20 KR KR1019980710980A patent/KR20000022534A/ko not_active Application Discontinuation
- 1997-06-20 WO PCT/EP1997/003251 patent/WO1997049674A1/en not_active Application Discontinuation
- 1997-06-20 PL PL97330897A patent/PL330897A1/xx unknown
- 1997-06-20 AU AU33422/97A patent/AU733938B2/en not_active Ceased
- 1997-06-20 EA EA199900057A patent/EA001432B1/ru not_active IP Right Cessation
- 1997-06-20 EP EP97929242A patent/EP0920414A1/en not_active Withdrawn
- 1997-06-20 CZ CZ984303A patent/CZ430398A3/cs unknown
- 1997-06-20 JP JP10502322A patent/JP2000514043A/ja active Pending
- 1997-06-25 ZA ZA9705631A patent/ZA975631B/xx unknown
- 1997-06-26 ID IDP972218A patent/ID17792A/id unknown
- 1997-06-26 AR ARP970102813A patent/AR008621A1/es unknown
-
1998
- 1998-12-22 NO NO986049A patent/NO986049L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PL330897A1 (en) | 1999-06-07 |
| EA001432B1 (ru) | 2001-02-26 |
| ZA975631B (en) | 1998-01-30 |
| KR20000022534A (ko) | 2000-04-25 |
| WO1997049674A1 (en) | 1997-12-31 |
| AR008621A1 (es) | 2000-02-09 |
| NO986049D0 (no) | 1998-12-22 |
| ID17792A (id) | 1998-01-29 |
| AU3342297A (en) | 1998-01-14 |
| EP0920414A1 (en) | 1999-06-09 |
| AU733938B2 (en) | 2001-05-31 |
| NZ333550A (en) | 2000-07-28 |
| TW460441B (en) | 2001-10-21 |
| EA199900057A1 (ru) | 1999-06-24 |
| BR9709902A (pt) | 1999-08-10 |
| IL127262A0 (en) | 1999-09-22 |
| CA2257404A1 (en) | 1997-12-31 |
| GB9613547D0 (en) | 1996-08-28 |
| JP2000514043A (ja) | 2000-10-24 |
| CZ430398A3 (cs) | 1999-08-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO986049L (no) | Matrise metallproteinaseinhibitorer | |
| DE69010375T2 (de) | Protease-Hemmer. | |
| AU6724796A (en) | Non-steroidal sulfatase inhibitor compounds and their method of use | |
| NO162467C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazo (1,5)-pyridiner og deres dihydro- og tetrahydroderivater. | |
| DE69512797D1 (en) | Prostaglandin-synthase hemmer | |
| IS7170A (is) | Bensóþíasepín og bensóþíadíasepínafleiður með tálmavirkni gegn dausgarnargallsýruflutningi (ileal bile acid transport, IBAT) til að meðhöndla fitudreyra | |
| BG108806A (en) | IIb/IIIa CELL ADHESION INHIIBITORS, METHOD FOR THE PRODUCTION, PHARMACEUTCIAL COMPOSITION AND ADMINISTRATION THEREOF | |
| NO941677L (no) | Tetrazolderivater av gallesyrer, fremgangsmåter for fremstilling og deres anvendelse som legemiddel | |
| NO302474B1 (no) | Sakarinderivater, farmasöytisk sammensetning og anvendelse derav | |
| NO991494L (no) | <beta>-sulfonylhydroksaminsyrer som matriksmetalloproteinaseinhibitorer | |
| HUT72436A (en) | Process for the production of imidazopyridines and pharmaceutical compositions containing them and which are suitable for treating gastro-intestinal diseases | |
| MX9803809A (es) | Inhibidores de hidroxamato de bifenilo de metaloproteinasas de matriz. | |
| AU7517400A (en) | N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent | |
| DK0567271T3 (da) | Steroidderivater til behandling af prostatahypertrofi, fremgangsmåde til fremstilling heraf og anvendelser heraf | |
| NO952205L (no) | Heterocykliske karbamater, fremgangsmåte for fremstilling derav og medikamenter | |
| ATE44748T1 (de) | 4-substituierte 6-alkylidene-androsten-3,17-dion- derivate und verfahren zu ihrer herstellung. | |
| HUP0101899A2 (hu) | Cisztein-aktivitástól függő enzimeket gátló hatású tiadiazolvegyületek, azokat tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| MX9702919A (es) | Derivados azo del acido 5-aminosalicilico para el tratameitno de la enfermedad inflamatoria intestinal. | |
| HUT53664A (en) | Process for producing enzyme inhibiting amino acid derivatives and pharmaceutical compositions comprising such compounds as active ingredient | |
| AU2223595A (en) | Aziridine derivatives, their production and use | |
| FI962323A0 (fi) | N-substituoidut atsabisykloheptaanijohdannaiset, kuten esim. neuroleptit | |
| IL95327A0 (en) | Method and composition for the treatment of cardiac and of vascular hypertrophy and hyperplasia | |
| CY2225B1 (en) | Organic compounds | |
| WO2003080631A3 (en) | Plasma carboxypeptidase b inhibitors | |
| NO983444D0 (no) | Benzo(c)kinolizin derivater, deres fremstilling og anvendelse som 5<alfa>-reduktaseinhibitorer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |